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Continuous addition of progenitors forms the
cardiac ventricle in zebrafish
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Jan Huisken 3,4, Daniela Panáková 2,5 & Christian Mosimann 1
The vertebrate heart develops from several progenitor lineages. After early-differentiating
first heart field (FHF) progenitors form the linear heart tube, late-differentiating second heart
field (SHF) progenitors extend the atrium and ventricle, and form inflow and outflow tracts
(IFT/OFT). However, the position and migration of late-differentiating progenitors during
heart formation remains unclear. Here, we track zebrafish heart development using trans-
genics based on the cardiopharyngeal gene tbx1. Live imaging uncovers a tbx1 reporter-
expressing cell sheath that continuously disseminates from the lateral plate mesoderm
towards the forming heart tube. High-speed imaging and optogenetic lineage tracing cor-
roborates that the zebrafish ventricle forms through continuous addition from the undiffer-
entiated progenitor sheath followed by late-phase accrual of the bulbus arteriosus (BA). FGF
inhibition during sheath migration reduces ventricle size and abolishes BA formation, refining
the window of FGF action during OFT formation. Our findings consolidate previous end-point
analyses and establish zebrafish ventricle formation as a continuous process.
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Vertebrate cardiomyocytes derive from an early vs. a late-differentiating progenitor pool within the anterior lateralplate mesoderm (ALPM) that can be divided into first
heart field (FHF) and second heart field (SHF)1. After the early-
differentiating FHF assembles the linear heart tube that in
mammals forms the left ventricle and parts of the atria, the late-
differentiating SHF contributes to the atria, right ventricle, and
OFT2–5. In mice, the SHF forms within the medial and posterior
epithelial-like field in the splanchnic ALPM on either side of the
FHF-derived cardiac crescent and is detectable through expres-
sion of markers including Fgf10 and Isl15–7. Defects in SHF
contribution to the heart lead to a broad variety of congenital
heart malformations affecting the arterial pole8. The original
purpose of a second, late-forming wave of the myocardium
remains unknown. An emerging concept places the SHF in close
developmental and evolutionary lineage relationship with phar-
yngeal and head muscle progenitors: in this context, the cardio-
pharyngeal field (CPF) is defined across chordate species as a
domain within the splanchnic or pharyngeal ALPM harboring
SHF and branchiomeric progenitor cells9. Consequently, a key
aspect of the SHF is its cardiac specification coordinated with
head muscle differentiation10.
The basic mechanisms of vertebrate heart formation are evo-
lutionarily conserved. Typical for teleosts, the zebrafish heart
consists of two chambers, an atrium and a ventricle (Fig. 1a). At
the arterial pole, the myocardium transitions into laminin-rich
myocardium referred to as conus arteriosus (CA) followed by the
elastic bulbus arteriosus (BA) that functions as a smooth-muscle-
based pressure capacitator similar to the mammalian aortic
arch11,12; the CA together with the BA is commonly, but not
consistently, defined as OFT12,13 (Fig. 1a). Cardiac progenitors
become detectable in the zebrafish ALPM by bilateral expression
of several conserved cardiac transcription factors, including
nkx2.5, hand2, and gata4/514–17. By 14–18 h post fertilization
(hpf), these bilateral progenitors condense at the midline as the
cardiac disk that forms the cardiac cone; the subsequently
emerging linear heart tube consists of the endocardium and the
surrounding early- differentiating cardiomyocytes referred to as
FHF myocardium, discernible at 16–18 hpf by differentiation
markers including myl718–20. Myocardial expression of drl-based
transgenes selectively marks FHF-derived cardiomyocytes from
late somitogenesis21. Starting from 26 hpf, akin to the mamma-
lian heart, a late-differentiating wave of prospective cardiomyo-
cytes and smooth-muscle cells extends the venous IFT and
arterial OFT of the beating zebrafish heart, referred to as SHF
lineage22–24 (Fig. 1a). The zebrafish heart therefore recapitulates
key processes of multi-chambered heart formation20.
Lineage tracing, several molecular markers including ltbp3, isl1,
and mef2c, or the maturation speed of fluorescent reporters have
been used to describe late-differentiating SHF-like myocardium
in zebrafish22–27. Nonetheless, the lineage separation and devel-
opmental connection between the ventricular myocardium and
OFT structures remain vaguely defined. Further, the position of
SHF-assigned cells during formation of the linear heart tube has
remained uncertain. Genetic lineage tracing has shown that both
the distal ventricle and OFT derive from nkx2.5- and ltbp3-
reporter-expressing cells24,28. nkx2.5:Kaede-based lineage track-
ing has indicated that most of the ventricular myocardium is
already condensed at the cardiac disk, but whether all these cells
then migrate with the emerging linear heart tube or stay behind
has remained unresolved29. nkx2.5:Kaede further marks a see-
mingly distinct group of cells posterior and outside of the forming
heart tube that also contributes myocardial progenitors to the
distal ventricle and OFT30; how these cells connect to the other
ventricular progenitors remains to be uncovered. Furthermore,
position-based cell-labeling experiments have mapped BA origins
to the medio-central region of the heart-forming ALPM that
corresponds to the expression domain of nkx2.5 and gata423, with
the proximal-most part of the BA arising from nkx2.5 reporter-
expressing pharyngeal arch 2 mesoderm29. Altogether, these
analyses support a model of addition of the majority of late-
differentiating myocardium to the ventricle and BA formation
after establishment of the linear heart tube.
The T-box transcription factor Tbx1 is expressed within the
CPF of various chordates and directs cardiac development by
maintaining proliferation and suppressing differentiation of SHF
cardiac progenitor cells9,31–33. Impaired TBX1 function in
humans results in DiGeorge syndrome32 with variable cardiac
defects, including tetralogy of Fallot, OFT defects, and an inter-
rupted aortic arch; defects that are recapitulated in Tbx1-mutant
mice34–36. The zebrafish tbx1 mutant van gogh (vgo) displays
among other phenotypes also defects in the pharyngeal arches
and a smaller BA, underlining the conserved function of Tbx1 in
CPF control37,38. The 12.8 kilobases (kb) upstream of the murine
Tbx1 gene as a transgenic reporter principally recapitulate
endogenous expression through separable Forkhead factor-
recruiting enhancers that drive pharyngeal/anterior endoderm
vs. mesoderm expression, including activity in the OFT39–41.
While these enhancers are sufficient in transgenic reporters,
endogenous Tbx1 expression is redundantly coordinated by
additional elements in the vicinity of the locus42.
Here, we isolate cis-regulatory elements from the zebrafish tbx1
locus to visualize the dynamics of ventricle and OFT formation.
Combining selective plane illumination microscopy (SPIM)
imaging with genetic and optogenetic lineage tracing, we capture
the formation of the linear heart tube with concomitant migration
of an undifferentiated sheath of tbx1 reporter-expressing cells that
are continuously added to, and gradually differentiate at, the
arterial pole of the heart. Meanwhile, BA progenitors reside in the
tbx1 reporter-positive pharyngeal ALPM and migrate later
toward the late-differentiating distal pole of the ventricle to
become smooth muscle cells. Combining chemical and genetic
perturbations, we find a distinct temporal requirement for FGF
signaling in controlling ventricle and BA size vs. BA specification.
In contrast to models that postulate a distant cellular origin and
stepwise addition of SHF cells, our findings establish that incor-
poration of the zebrafish ventricle and OFT structures into the
linear heart tube is a continuous process with distinct phases of
FGF activity during CPF differentiation.
Results
Activity of zebrafish tbx1 regulatory elements. In our ongoing
efforts to isolate cis-regulatory elements active within the lateral
plate mesoderm (LPM) to observe cardiovascular cell fate parti-
tioning, we generated zebrafish tbx1 reporter transgenics based on
the high ranking of tbx1 expression in transcriptome analysis of
zebrafish LPM (within top-20 enriched genes)21. Transgenic
reporters in mice have established core regulatory elements suf-
ficient for recapitulating Tbx1 expression41. Consistently, we
observed specific EGFP reporter activity driven by the 3.2-kb
upstream region of zebrafish tbx1 in embryos carrying transgenic
insertions of Tg(–3.2tbx1:EGFP), with minimal variability
between six individual transgenic lines (Fig. 1b, Supplementary
Fig. 1, Supplementary Table 1).
In late epiboly, tbx1:EGFP akin to endogenous tbx1 expression
broadly labels a dorsal/anterior domain (Fig. 1c, Supplementary
Fig. 1). During somitogenesis, tbx1:EGFP expression is detectable
in anterior bilateral domains (Fig. 1d, e) and at 36 hpf in the
pharyngeal arches and in the heart (Fig. 1f). While we do not
detect significant endogenous tbx1 mRNA expression in the heart
consistent with previous reports43, we readily observed tbx1:
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EGFP expression in cardiac precursors, indicating distinct
dynamics of our reporter compared to endogenous tbx1 akin to
mouse Tbx1 reporters (Supplementary Fig. 1)39–41. To resolve
tbx1 reporter expression in relation to the drl-labeled LPM21, we
performed in toto panoramic SPIM imaging44 on tbx1:EGFP;drl:
mCherry transgenic embryos from gastrulation (70% epiboly) to
mid-somitogenesis (15 hpf) (Supplementary Movie 1). At late
epiboly to tailbud stages, when the LPM condenses around the
embryo margin, we detected overlapping tbx1:EGFP expression
in drl:mCherry-expressing LPM cells, medial within the ALPM
and lateral-most within the tbx1 reporter-expressing domain
(Fig. 1g–j). These cells condensed further at the margin of the
tbx1:EGFP-expressing domain throughout early somitogenesis
(Fig. 1k–n). Thus, a subpopulation of the tbx1 reporter-expressing
cells represents ALPM, while the medial field of tbx1 reporter-
positive cells potentially represents endoderm precursors, as we
observe the labeling of endodermal derivatives (i) in 3 days post
fertilization (dpf) tbx1:EGFP-expressing embryos, as well as (ii)
with CreERT2/lox-mediated lineage tracing with tbx1:creERT2
(Tg(–3.2tbx1:creERT2)zh703) and hsp70l:Switch (Tg(–1.5hsp70l:
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Fig. 1 tbx1 reporter expression and lineage contribution in the cardiopharyngeal field and ALPM. a Confocal Z-projection and schematic representation of a
72-hpf zebrafish heart with two chambers, the ventricle (V) and atrium (A) separated by a valve at the atrioventricular canal (AVC). The isolated heart is
stained for MHC marking the myocardium (magenta) and a-PKC marking all cells (green). The FHF-assigned myocardium contains the proximal ventricle
(pV) and the majority of the atrium (A), SHF-assigned myocardium forms the distal ventricle (dV) and outflow tract (OFT), shown in magenta and green in
the schematic, respectively. The OFT includes the conus arteriosus (CA), comprising the myocardial connection of the ventricle to the bulbus arteriosus
(BA), and the smooth muscular BA itself. The lineage contributions to the sinus venosus (SV)/inflow tract (IFT) and developmental timing of IFT valve
formation remain unresolved. IC: inner curvature, OC: outer curvature. b Genomic locus of the zebrafish tbx1 gene; the red line indicates a 3.2-kb cis-
regulatory region amplified to drive reporter transgenics. c Representative tbx1:EGFP reporter transgene expression in a dorsal/anterior field during
gastrulation (90% epiboly, dorsal/anterior to the left). d, e tbx1:EGFP at 14 ss; dorsal (d) and lateral views (e) of the prospective cardiopharyngeal field (CPF,
arrowheads). f Lateral view of a 36-hpf tbx1:EGFP embryo with EGFP expression in the CPF-derived pharyngeal arches (pa3–7) and heart (asterisk). EGFP
expression also marks the prechordal mesoderm-derived hatching gland (hg). c–f Insets depict bright-field images of the respective fluorescent images. g–n
Mercator projection of representative stages from panoramic SPIM-imaged tbx1:EGFP;drl:mCherry double-positive transgenic embryos (n= 3); dorsal views.
tbx1:EGFP expression is confined to the anterior of the embryo, with no EGFP signal in the posterior LPM (PLPM). Expression in the notochord (nc) and
hatching gland (hg) is likely related to early prechordal plate activity of the reporter. Note the double-positive cells at the outermost domain of the tbx1:EGFP-
positive anterior cell population (arrowheads and bracket). Scale bars 10 μm (a), 100 μm (c), 200 μm (d, e), and 500 μm (f). g–n Anterior to the left
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loxP-STOP-loxP-EGFP,cryaa:Venus)zh701) transgenics (Supple-
mentary Fig. 2). Moreover, cranial cartilage is labeled by tbx1
reporter expression and with tbx1:creERT2-mediated lineage
tracing, suggesting additional tbx1 reporter expression in neural
crest lineages (Supplementary Fig. 2). Taken together, transgenic
zebrafish reporter expression based on the upstream 3.2-kb tbx1
cis-regulatory region approximates key aspects of reported Tbx1
activity9,31,45 and visualizes a dynamic anterior endoderm and
mesoderm domain that includes ALPM.
tbx1 reporter cells contribute to venous and arterial poles. To
resolve cardiac tbx1:EGFP expression, we analyzed tbx1:EGFP
transgenics co-stained for the differentiated cardiomyocyte-
expressed myosin heavy chain 1E (MHC) (Fig. 2a–h). At 26
hpf, when the differentiating cardiomyocytes in the linear heart
tube represent FHF derivatives21,27, we detected tbx1 reporter
expression in most of the differentiated ventricular cardiomyo-
cytes and additionally in two MHC-negative domains at the IFT
and OFT (Fig. 2a–h). At 26 hpf, we detected that at the IFT of the
linear heart tube, on average, 77.3% of tbx1:EGFP cells are
positive for Isl1, while only 22.7% are Isl1-positive alone (n= 11;
Fig. 2i–p, q, Supplementary Movie 2), consistent with inferred
SHF identity of IFT cells25,27,46.
To corroborate which cardiac lineages form from tbx1 repor-
ter-expressing cells, we performed genetic lineage tracing with
tbx1:creERT2 (Fig. 2r). 4-OHT induction of CreERT2 starting
from shield stage to 90% epiboly (6–9 hpf) labeled ventricular
cardiomyocytes, including the distal ventricle and OFT region,
scattered atrial cells around the IFT, and the diaminorhodamine-
4M AM (DAR-4M)-reactive smooth-muscle cells in the BA13
(Fig. 2s–u, y-a′, Supplementary Fig. 3). These cardiac descendants
of tbx1 reporter-expressing cells likely derive from ALPM: pan-
LPM lineage tracing using drl:creERT2 from 90% epiboly broadly
marks atrial and ventricular myocardium plus the DAR-4M-
stained BA (Fig. 2v–x, y-a′, Supplementary Fig. 3), in line with
previous LPM labeling by drl:creERT221,47 and selective ALPM
tracing of OFT structures28,29. While drl-mediated ALPM lineage
tracing labeled the endocardium, cranial vessels (Fig. 2s–u,
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Fig. 2 tbx1+ cells contribute to LPM-derived cardiac lineages. a–p Representative maximum intensity projections of whole-mount tbx1:EGFP-expressing
embryos counterstained for anti-EGFP and anti-MHC (n= 3) (a–h) or anti-Isl1 (n= 11) (i–p) at 26 hpf; lateral views, anterior to the left. a–d tbx1 reporter
expression can be detected in the MHC-positive linear heart tube and in the MHC-negative poles at the cardiac inflow and outflow tracts (arrowheads);
e–h depicts a 2.25x magnification of the framed area in a–d. tbx1:EGFP also marks the pharyngeal arches (pa) and endothelial cells of the cranial vasculature
(cv) (d). i–p tbx1 reporter-expressing cells at the IFT co-express the SHF marker Isl1 (asterisks n, o); m–p depicts a 3x magnification of the framed area in
i–l. q Quantification of tbx1:EGFP/Isl1 double- compared to Isl1 single-positive cells at the IFT of the linear heart tube, n= 11 individual embryos analyzed,
means ± s.d. r Lineage tracing of tbx1 and drl reporter-expressing cells, shown in representative embryos. tbx1:creERT2 (n= 11) or drl:creERT2 (n= 3)
transgenics, respectively, were crossed to the ubiquitous hsp70l:Switch loxP tracer line, embryos were 4-OHT-induced at 90% epiboly, and heat-shocked at
3 dpf. s-a’ Live SPIM imaging of still hearts of representative lineage-traced and control embryos; maximum intensity projections of ventral views, anterior
to the top, dashed outlines mark the heart with the bulbus arteriosus (BA), atrium (A), and ventricle (V). s–u tbx1:creERT2 lineage tracing (tbx1 > EGFP) at
late gastrulation labels myl7:DsRed2-expressing cardiomyocytes (arrowheads) in the ventricle and inflow tract of the atrium, and DAR-4M-stained cells
(arrowhead) in the BA. v–x drl:creERT2-mediated lineage tracing (drl > EGFP) at 90% epiboly marks all cardiomyocytes (arrowheads) in the ventricle and
atrium, BA cells (arrowhead), and the endocardium (arrows). y-a’ tbx1:creERT2;hsp70l:Switch transgenics without 4-OHT treatment and heat-shocked at 3
dpf show no specific EGFP expression (asterisks mark the autofluorescent pigment cell). Scale bars 20 μm (e–h, m–p), 100 μm (a–d, i–l, s–a’)
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Supplementary Fig. 3), and several head muscle groups
(Supplementary Fig. 3), tbx1 reporter expression and lineage
tracing labeled the same structures without the endocardium, but
additionally also craniofacial cartilage and endoderm derivatives,
in line with Tbx1 as a CPF marker9 (Fig. 2d, s, Supplementary
Figs. 2, 3). These results indicate that the tbx1 reporter expression
domain entails ALPM-derived cells that contribute to cardiac
lineages including IFT and OFT structures.
tbx1+ progenitors migrate with the linear heart tube. By end-
point analysis in zebrafish, different positions and migration
dynamics have been assigned to IFT-, ventricle-, and OFT-
contributing undifferentiated SHF progenitors, including delayed
migration from pharyngeal ALPM22,23, condensation with the
forming cardiac disk29, and localization posterior to the forming
cardiac cone30. To visualize the cardiac tbx1 reporter-expressing
cells, we SPIM-imaged tbx1:EGFP;drl:mCherry embryos from 16
hpf (14 ss) to 22–24 hpf to capture all stages of heart field
migration up to the onset of heartbeat (Supplementary Movie 3).
Of note, at these stages, drl:mCherry expression in the heart field
gradually confines from previous pan-LPM expression to
restricted expression in FHF-derived lineages and robust
expression in the endocardium21. At 14 ss, the drl:mCherry-
expressing heart field is arranged as a bilateral LPM domain as is
the nearly overlapping tbx1:EGFP-expressing field before con-
densing at the midline (Fig. 3a–f). From approximately 16 ss
onward, while midline-centered migration and formation of the
drl:mCherry-positive cardiac disk completed, tbx1:EGFP-positive
cells contributed to the cardiac disk (Fig. 3d–f) and further dis-
seminated from the bilateral tbx1 reporter domain to migrate
medially along drl-positive endothelial progenitors (Fig. 3g–i). At
22 hpf, tbx1 reporter-positive cells formed a sheath of cells at the
prospective arterial pole of both tbx1 and drl reporter-expressing
linear heart tube (Fig. 3j–l). 3D segmentation confirmed that in its
entirety, the tbx1 reporter-positive cell population surrounded the
growing endocardium like a sleeve trailing outward to the still
bilateral progenitors (Fig. 3m–o, Supplementary Movie 4). These
observations suggest co-migration of tbx1 reporter-expressing
cells as part of the forming, jogging linear heart tube and con-
tinuous with the prospective arterial pole (Fig. 3m–o).
The tbx1+ domain is continuous with the early myocardium.
To understand the formation of the arterial pole of the heart tube
in greater detail, we imaged tbx1:EGFP;myl7:DsRed2 double-
transgenic embryos from 18 to 30 hpf (Supplementary Movie 5,
Supplementary Fig. 4). The slow folding of DsRed2 during this
time frame discriminates between the early differentiated,
DsRed2-positive (FHF-assigned), and the later-differentiating,
DsRed2-negative (SHF-assigned) myl7-expressing
cardiomyocytes26,27. Correspondingly, we detected myl7:DsRed2
expression in the migrating and differentiating heart tube from
24 hpf onward (Supplementary Fig. 4). We observed tbx1 repor-
ter-expressing cells at the arterial pole of the heart tube (i) that
based on the absence of myl7:DsRed2 expression throughout
24–30 hpf correspond to the later-differentiating SHF myo-
cardium, and (ii) that were connected to, and migrated together
with, the myl7-positive myocardium (Supplementary Fig. 4).
To overcome the complications of live-tracking associated with
the onset of heartbeat at 24 hpf with continued ventral and rostral
heart tube migration21–23,28, we performed SPIM-based high-
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speed imaging and reconstruction of the beating zebrafish heart
from 28 to 52 hpf48. We imaged tbx1:EGFP;myl7:DsRed2 embryos
from a lateral view (right side) to optimally resolve the migrating
and looping ventricle (Fig. 4a–c, Supplementary Movie 6).
Linking to our previous time course, we observed the tbx1:
EGFP-positive/myl7:DsRed2-negative cells connected to the
differentiating, myl7:DsRed2-fluorescent myocardium at 28 hpf
(Fig. 4a); displacement of these cells due to the beating
differentiated myocardium supports their continuous incorpora-
tion into the heart tube (Supplementary Movie 7). Throughout
ventricle looping, the initially solely tbx1 reporter-positive cells
became re-arranged within the ventricle, intercalated with myl7:
DsRed2-expressing differentiated cardiomyocytes, and gradually
turned on myl7:DsRed2 expression (Fig. 4b, c), in agreement with
the previously described late SHF-derived myocardial
differentiation22,24,27. Imaging of still hearts showed that all
ventricle-incorporated tbx1:EGFP-expressing cells were differen-
tiated and expressed myl7:DsRed2 by 54 hpf (Fig. 4d). In
addition, tbx1 reporter-expressing, undifferentiated cells that
gradually upregulated myl7 expression also appeared at the IFT
(Fig. 4a–c).
In our time-lapse, we noted that from time point 35 onward
(~39 hpf), a new cluster of tbx1 reporter-expressing cells appeared
at the OFT that expanded throughout the rest of recorded cardiac
development, but never crossed into the ventricle (Fig. 4b, c,
Supplementary Movie 6); we hypothesized that these cells are BA
progenitors. Indeed, we detected tbx1:EGFP expression in the
differentiated BA smooth muscle at 3-4 dpf (Fig. 4e), consistent
with our genetic lineage tracing (Fig. 2s–u). We corroborated our
live-imaging data by examining tbx1:EGFP reporter expression in
dissected hearts of transgenic embryos at 26, 54, and 72 hpf
(Fig. 4f–n); quantification documented no overt change in the
number of tbx1:EGFP-positive ventricular cardiomyocytes over
the three observed time points (Fig. 4h). At 26 hpf, we observed
tbx1:EGFP-positive cells at the distal ventricle of hearts that did
not express MHC at this time (Fig. 4f, g), and at 54 hpf, we
detected differentiated cardiomyocytes expressing tbx1:EGFP as
well as potential BA precursors at the OFT that did not express
MHC (Fig. 4i–k). At 3 dpf, the differentiated smooth muscle but
not the endothelium of the BA was clearly marked by tbx1:EGFP
expression (Fig. 4l–n, Supplementary Fig. 4).
Altogether, our live-imaging data confirmed by analysis in
isolated hearts (i) provide real-time observation of late-
differentiating ventricle myocardium, and (ii) confirm that
tbx1 reporter-positive cells that comigrate with the early-
differentiating cardiac cone subsequently differentiate to ventri-
cular cardiomyocytes, including the late-differentiating myocar-
dial pool at the arterial pole24,27. Moreover, we detect a second
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reporter expression (b, c). The dashed line (b, c) indicates the distal end of the ventricle and the arrowheads point to tbx1:EGFP-expressing cells at the OFT
that never cross into the ventricle and are likely BA precursors. d, e Maximum intensity projections of SPIM-imaged tbx1:EGFP;myl7:DsRed2 double-positive
transgenic hearts stopped from contracting with BDM at 54 hpf (n= 3) or 3.5 dpf (n= 7), respectively; ventral views, anterior to the top. tbx1 reporter
expression can be detected in differentiated tbx1/myl7 reporter double-positive cardiomyocytes (arrows d, e), the tbx1+/myl7- OFT at 54 hpf (arrowhead
d), and the tbx1+/myl7- BA at 3.5 dpf (asterisk e). f, g, i–n Top-down 2-µm confocal section of isolated zebrafish hearts at 26 (f, g), 54 (i–k), and 72 hpf (l–
n) from tbx1:EGFP, counterstained with anti-GFP and anti-MHC; OFT/BA to the top, sinoatrial node (SAN) or atrium (A) to the bottom left, and ventricle
(V) to the top left. k, n A magnification of the framed area in j, m. f, g tbx1:EGFP is expressed at the MHC-negative arterial pole (AP) of the heart tube
(arrowhead). h Quantification of the tbx1:EGFP-positive ventricular cardiomyocytes compared to whole ventricle (in percentage) reveals no change over
developmental period from 26 hpf (n= 5), 54 hpf (n= 11), to 72 hpf (n= 15). Each data point represents averaged percentage per heart; means ± s.d. i–k At
54 hpf, cardiomyocytes of the later-differentiated distal ventricle express tbx1:EGFP (arrowhead), as do MHC-negative progenitors of the OFT (asterisks).
l–n The differentiated BA at 3 dpf is positive for tbx1:EGFP. Scale bars 200 µm (d, e), 10 µm (f, g, i–n)
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phase of tbx1 reporter-expressing cells adding to the heart at later
stages and potentially making the smooth muscle of the BA.
The tbx1 sheath forms ventricular myocardium. While corre-
sponding to our tbx1:creERT2 lineage tracing (Fig. 2s–u), active
EGFP reporter expression is not strict evidence for lineage asso-
ciation. To confirm the lineage contribution of the tbx1 reporter-
expressing cardiac sheath to the ventricular myocardium and
OFT, we performed optogenetic lineage tracing using the trans-
genic line Tg(–3.2tbx1:H2B-Dendra2)zh704 (subsequently as tbx1:
Dendra2); in tbx1:Dendra2, a nuclear histone 2B-linked Dendra2
fluorophore is constitutively green-fluorescent and turns irre-
versibly red upon photoconversion49. We photoconverted tbx1:
Dendra2-positive cells of the cardiac cone and trailing sheath at
22 hpf (Fig. 5a, b) and detected Dendra2-red positive cardio-
myocytes at 3.5 dpf throughout the ventricle, including the SHF-
assigned distal portion and the inner curvature (n= 10/11, N= 4;
n: total number of individual embryos analyzed, N: number of
individual experiments performed; Fig. 5c–e, Supplementary
Fig. 5). These observations suggest that the tbx1:Dendra2-
expressing sheath contributes to FHF- and SHF-linked ven-
tricular myocytes. When converting tbx1:Dendra2-expressing
cells at the base of and posterior to the cone in the area previously
assigned to harbor additional myocardial SHF precursors30
(Fig. 5f, g), we detected a few distal cardiomyocytes only on the
dorsal side of the ventricle labeled by Dendra2-red (n= 3/3, N=
1; Fig. 5h–j). We identified the majority of the ventricle to be
derived from tbx1:Dendra2-expressing cells present already in the
cone and only a small fraction of cardiomyocytes to follow later.
SHF contribution was previously reported to comprise 40–50% of
the ventricular myocardium21,22,24; thus, our data suggest that the
majority of late-differentiating cardiomyocyte progenitors enter
the heart trailing the early-differentiating ventricular progenitors
by 22 hpf and as part of a continuous tbx1 reporter-expressing
cell sheath.
In contrast to ventricular cardiomyocytes, we could not detect
any Dendra2-red cells in the BA after photoconversion at the
trailing end of the cardiac cone (n= 0/11, N= 4; Fig. 5a–e,
Supplementary Fig. 5, red signal due to autofluorescence from
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Fig. 5 The tbx1+ cone forms the ventricular myocardium but not the BA. a, f, k, p Maximum intensity projections and schematics of representative
photoconverted (a, f, k) or control (p) tbx1:Dendra2 embryos; dorsal views, anterior to the top. At 22 hpf, tbx1:Dendra2-expressing embryos were
illuminated with a 405-nm laser in a confined region of interest to convert Dendra2-green to Dendra2-red in specific tbx1 reporter-expressing domains. c, h,
m, r SPIM-imaged hearts and graphical representations of embryos photoconverted as in a, f, k and p and stopped from contracting with BDM at 3.5 dpf;
maximum intensity projections (c, d, m, n, r, s) or optical Z-section (h, i), ventral views, anterior to the top. a–e Dendra2-red-positive sheath cells give rise
to ventricular cardiomyocytes, including the SHF-derived distal ventricle, but not to the BA. The red signal within the BA (b) derives from autofluorescent
blood also detected in non-photoconverted tbx1:Dendra2 embryos (see p–t). f–jMedial migrating cells posterior to the cardiac cone contribute to the most
distal myocardium at the dorsal side of the heart (arrowhead in h, i) and to a proximal portion of the BA in 3/3 analyzed embryos. k–o Photoconversion of a
broad area in the tbx1:Dendra2-positive pharyngeal ALPM posterior to and on the right of the linear heart tube marks the right side of the BA (dotted
outline in n). p–t Red signals in the chambers and on top of the pericardium are due to unspecific autofluorescence also detected in controls. Scale bars 50
µm
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blood, compare to Fig. 5k–n, p–t). In contrast, consistent with
earlier position-based lineage tracing23,29, we detected Dendra2-
red-positive cells in the BA when converting the pharyngeal
ALPM lateral to the forming cardiac cone (n= 15/15, N= 4;
Fig. 5k–o). The right and left sides of the BA were exclusively
formed from the corresponding side with no discernible crossover
(n= 3/3 left side and n= 3/3 right side, total n= 6/6, N= 3;
Fig. 5k–o, Supplementary Fig. 6). Moreover, different regions of
the pharyngeal ALPM contributed to different parts of the BA on
a proximal-to-distal axis and additionally labeled different
craniofacial structures (n= 3/3 proximal part, n= 3/3 medial
part, n= 3/3 distal part, N= 2; Fig. 5k–o; Supplementary Fig. 6).
Taken together, our data document that the majority of, if not all,
ventricular cardiomyocytes stem from a tbx1 reporter-expressing
progenitor sheath that participates in cardiac ALPM fusion,
contributes to the linear heart tube, and trails the prospective
arterial pole. In contrast, SHF-assigned BA precursors within the
pharyngeal ALPM add to the heart at a subsequent stage as more
distantly trailing cells, as has been reported for OFT lineages in
mammals4,5.
FGF signaling controls tbx1+ progenitor addition. FGF sig-
naling influences cardiac patterning, including SHF development
in various chordates50. Correspondingly, zebrafish embryos
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mutant for fgf8a (acerebellar, ace) or upon fgf8a morpholino
knockdown form a severely hypoplastic ventricle with compar-
ably normal atrium27,51. Moreover, chemical perturbations using
the pan-FGF signaling inhibitor SU540252–54 from the earliest
phases of heart formation result in reduced late-differentiating
myocardium and loss of SHF marker expression at the arterial
pole22,27.
To determine the temporal requirement for FGF signaling on
the different phases of cardiac contribution from the tbx1 repor-
ter-expressing ALPM field, we first revisited the fgf8a phenotype
using the verified fgf8a translation-blocking morpholino MO3-
fgf8aATG 55 (Fig. 6a–i). We measured ventricle and BA size upon
fgf8a perturbation in isolated hearts and compared them to hearts
of control morpholino-injected embryos: fgf8a morphants still
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faithfully expressed tbx1:EGFP with no significant change of
reporter-expressing cardiomyocyte number within the ventricle
(Fig. 6i) and formed a BA (Fig. 6d–f), yet both ventricle and BA
were significantly smaller with less cells (Fig. 6g, h) consistent
with previous reports27,51,54. The impact on ventricle and BA size
is unlikely from a strong disruption of early- vs. late-
differentiating myocardium (FHF or SHF territories, respec-
tively), as at 54-hpf expression of drl:EGFP that demarcates FHF-
derived myocardium21 appeared insignificantly affected upon
fgf8a perturbation (Fig. 6j–p).
To resolve the temporal influence of FGF signaling, we treated
tbx1:EGFP embryos with SU5402 when tbx1 reporter-expressing
ventricular progenitors migrate to contribute to the forming heart
tube. When we initiated SU5402 treatment before medial
migration at 14 ss and perturbed FGF signaling throughout sheath
migration (pulse treatment from 14 ss to 22 hpf), 5 µM SU5402-
treated embryos showed diminished but still ongoing migration of
the tbx1:EGFP-expressing sheath by 26 hpf (Fig. 7a–f). At 3.5 dpf,
the ventricle of these embryos contained tbx1:EGFP-expressing
cardiomyocytes (Fig. 7g–l, Supplementary Movie 8). We observed
similar results when continuously perturbing FGF signaling with a
lower dose of 2 µM SU5402 from 14 ss onward till imaging at 3.5
dpf (Fig. 7m–o, Supplementary Movie 9). In line with previous
findings54, the ventricles of pulse (5 µM, 14 ss–22 hpf) or
continuously (2 µM, from 14 ss to imaging at 3.5 dpf) SU5402-
treated embryos were significantly smaller (Fig. 7p), while the size
of the atrium was not significantly changed (Fig. 7q). These results
demonstrate an impact of FGF signaling during tbx1 reporter-
expressing sheath migration, consistent with an early role of FGF
signaling in ventricle formation.
In contrast to the mere reduction in ventricle size upon FGF
inhibition (Fig. 7g–p), we observed a more striking effect on BA
addition when perturbing FGF signaling during tbx1 reporter-
expressing sheath migration (Fig. 7r). To better resolve the
temporal requirement of FGF signaling in this process, we treated
tbx1 reporter-expressing or DAR-4M-labeled embryos with an
early (14 ss–22 hpf) or late (24 hpf–28/34 hpf) pulse of SU5402
(Fig. 7s–x; Supplementary Fig. 7). Even though BA addition takes
place after primary heart tube formation at 24 hpf, BA formation
was completely absent when assessed at 3.5 dpf in a substantial
number of embryos pulse-treated between 14 ss and 22 hpf with
5 µM SU5402 (Fig. 7u, v, y; Supplementary Fig. 7). While pulsing
SU5402 treatment between 14 ss and 22 hpf with 2 µM SU5402
invariantly allowed for detectable BA differentiation, the majority
of embryos continuously treated from 14 ss onward with 2 µM
SU5402 failed to form a BA (Fig. 7u, v, y). In contrast, SU5402
pulse treatment after heart tube formation from 24 hpf to 28 hpf
or to 34 hpf merely caused formation of smaller BA and never
caused loss of the differentiated BA, as confirmed by DAR-4M;
this effect was also dependent on the SU5402 concentration
(Fig. 7w–y, Supplementary Fig. 7).
Taken together, our data determine a temporally defined
requirement for FGF signaling during formation and migration of
the ventricle progenitor sheath. Further, our findings support a
model in which differential levels and timing of FGF control the
continuous addition of ventricle and BA progenitors to the heart
tube, with a sensitive window for BA determination before its
progenitors leave the pharyngeal ALPM.
Discussion
The concept of distinct phases of differentiating cell types con-
tributing to individual parts of the multi-chambered heart is
deeply rooted in chordate evolution. Here, we visualized the
formation of the zebrafish ventricle and OFT structures from a
continuously differentiating progenitor sheath that emerges from
tbx1 reporter-expressing ALPM and surrounds the emerging
endocardium. Our data connect, are consistent with, and extend
previous end-point analyses of early- vs. late-differentiating
myocardium and the formation of OFT structures including the
BA. We further reveal a temporal influence and sensitivity of FGF
signaling on ventricle myocardium vs. BA smooth-muscle for-
mation in zebrafish. Our work emphasizes cardiac development
as part of a tbx1-expressing cardiopharyngeal progenitor field
within the bilateral ALPM that is already significantly pre-
patterned before its medial migration forms the heart.
Reporter expression and lineage tracing (Figs. 1, 2, Supple-
mentary Figs. 2, 3) established the isolated zebrafish tbx1 cis-
regulatory region as a putative marker of the CPF that resides
within the ALPM aside cranial endoderm and neural crest
lineages. We have combined different strategies to demonstrate
that our tbx1 regulatory elements visualize early- as well as late-
differentiating cardiac lineages. When live-imaging tbx1:EGFP-
expressing embryos from stages before heart field migration
(14 ss) up to cardiac looping stages (54 hpf), we robustly detected
tbx1 reporter-expressing cells at the arterial pole of the ventricle
that were connected to the differentiated myl7-expressing myo-
cardium and started moving in sync with heartbeat of the pri-
mitive heart tube (Figs. 3, 4, Supplementary Movies 3–7); this
observation suggests that undifferentiated tbx1 reporter-expres-
sing cells are already physically linked to beating cardiomyocytes.
These tbx1:EGFP-expressing progenitors then gradually upregu-
lated myl7 expression, confirming their identity as cardiomyocyte
progenitors equivalent to late-differentiating SHF-liked cells
(Fig. 4a–c, Supplementary Movie 6)26,27. Independent of
Fig. 7 FGF signaling differentially affects tbx1+ ventricular and BA precursors. a–f Maximum intensity projections of representative tbx1:EGFP;drl:mCherry
DMSO-treated controls or embryos treated with 5 µM SU5402 from 14 ss to 22 hpf; lateral/dorsal view, anterior to the left. FGF signaling-perturbed
embryos show a defect in the tbx1:EGFP-expressing sheath (arrowhead) at the base of the forming heart tube (outline). g–oMaximum intensity projections
of representative hearts of tbx1:EGFP;myl7:DsRed2 embryos, DMSO-treated controls (g–i, n= 5), treated with 5 µM SU5402 between 14 ss and 24 hpf (j–l,
n= 8), or treated with 2 µM SU5402 continuously from 14 ss (m–o, n= 3); ventral views, anterior to the top, outlines mark the heart. FGF-perturbed
embryos retain normal contribution of tbx1:EGFP-expressing cardiomyocytes to the ventricle upon pulsed or continuous signaling inhibition; ventricle (V),
atrium (A), bulbus arteriosus (BA), and asterisks mark the missing BA upon SU5402 treatments. p–r Quantified ventricle, atrium, and BA area size in
SU5402-treated embryos as in g–o. Pulsed (see j–l) or continuous (see m–o) FGF signaling inhibition diminishes ventricle size (p) and severely reduced to
abolished addition of the tbx1 reporter-expressing BA (r). The atrium is not significantly affected (q). Means ± SEM. ns P > 0.05, *P≤ 0.05, **P≤ 0.01,
***P≤ 0.001, and ****P≤ 0.0001, unpaired t-test with Welch correction. s–y SU5402 treatments affect BA development in time- and concentration-
dependent manner; n indicates the number of embryos analyzed per condition, N indicates the number of experiments performed. s–x tbx1:EGFP;myl7:
DsRed transgenic controls and embryos treated with DMSO or 5 µM SU5402 during (14 ss–22 hpf) or after (24 hp–28 hpf) heart tube formation; lateral
views, anterior to the left. Absent BA formation can only be observed in embryos treated with SU5402 from mid-somitogenesis to heart tube stages
(arrowhead in u, v, compare to s, t), but not when signaling inhibition is initiated at 24 hpf (arrowhead in w, x). y Quantification of the concentration-
dependent effect on BA formation in FGF signaling-perturbed tbx1:EGFP;myl7:Red or DAR-4M-stained myl7:EGFP transgenics (see Supplementary Fig. 7).
For 5 µM SU5402 from 14 ss to 22 hpf, no BA in n= 29/43 as assessed by tbx1 reporter and n= 5/15 by DAR-4M, total n= 34/58, N= 4; DMSO-treated
controls: normal BA in n= 58/58 by tbx1 reporter and n= 10/10 by DAR-4M, total n= 68/68, N= 4. Scale bars 50 µm (g, o), 100 μm (a–f, s–x)
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continued tbx1 reporter activity, genetic and optogenetic lineage
tracking supports the notion that most, and likely all, FHF- and
SHF-assigned ventricular cardiomyocytes are contained within
the tbx1 reporter-expressing sheath that contributes to the cardiac
cone and trails into the bilateral ALPM (Fig. 5a–j, Supplementary
Fig. 5). Of note, the SHF in mouse has been characterized as
epithelial sheet that undergoes epithelial-to-mesenchymal tran-
sitions and tension changes during its addition to the heart tube7.
Our observations hint at similar dynamics of SHF cells in teleosts.
The observed addition of ventricle progenitors as a continuous
process connects previously observed key time points of SHF-
assigned, late-differentiating myocardium addition to the zebra-
fish heart tube21,22,24,29. Nonetheless, the position of SHF-
assigned cells during heart tube assembly had previously
remained ambiguous. nkx2.5:Kaede reporter-based optogenetic
lineage tracking showed that most if not all ventricular myo-
cardium is already condensed at the cardiac disk, but whether
these cells then migrate with the emerging primitive heart tube or
stay behind had remained unresolved29. A distinct group of
nkx2.5:Kaede-expressing cells were found more posterior, see-
mingly outside of the forming heart tube, and shown to form a
small portion of the distal ventricle and OFT myocardium30. Our
tbx1 reporter transgenics now consolidate these data points as
parts of the continuous cell sheath forming the ventricle.
On the contrary, smooth-muscle cells in the BA contributed
from the still bilateral pharyngeal ALPM lateral and posterior to
the developing heart tube (Fig. 5k–o, Supplementary Fig. 6), a
development that also appears in our live-imaging data (from
~39 hpf, time point 35 in Fig. 4b, c, Supplementary Movie 6).
Inferred by reporter expression and not strictly lineage data, our
analysis of dissected hearts at 54 hpf (Fig. 4f–n) confirms the
existence of a tbx1 reporter-expressing, non-myocardial cell
population at the OFT pole, the position where we later find the
differentiated BA (Fig. 4e, l–n). Addition of BA precursors to the
distal ventricle has been reported as early as 48 hpf by 4,5-dia-
minofluorescein diacetate (DAF-2DA) staining that senses nitric
oxide accumulating in the BA and likely requires functional
maturation of smooth muscle13. A concise working definition
(proposed in Fig. 1a) to distinguish between distal ventricle
myocardium, collagenous OFT myocardium of the CA, and BA
could further consolidate the various reports of distinct waves of
SHF-assigned cells to the heart tube that have been referred to by
mixed nomenclature12. Our data establish the accrual of ventricle
myocardium and the subsequent addition of smooth-muscle
progenitors as distinct phases of a continuous process.
FGF signaling has been previously reported to govern pro-
genitor addition to the arterial pole of the zebrafish heart22,27.
Consistent with these previous findings, we observed a dimin-
ished ventricle upon pan-FGF signaling perturbation during
tbx1 reporter-expressing sheath formation (Fig. 7g–o). We further
detected absent BA formation when initiating chemical FGF
signaling inhibition already before cardiac cone formation
(Fig. 7h–l). In contrast, knockdown of the key cardiac FGF ligand
gene fgf8a merely caused a smaller ventricle and BA (Fig. 6a–h),
akin to pulsed exposure to a low dose of SU5402 during ventricle
formation and BA accrual at 14 ss–22 hpf (Fig. 7f–h). To our
knowledge, the drastic temporal influence of FGF signaling on BA
formation has not been previously described in zebrafish. To
exclude that the observed loss of the BA was not caused by edema
formation that could potentially induce apoptosis due to exten-
sive stretching forces, we analyzed BA formation in tbx5a mor-
phants exhibiting the heartstring phenotype: in all analyzed tbx5a
morphants that develop the reported heartstring phenotype (as
well as milder forms of looping defects in tbx5amorphants)56, the
BA was properly formed and could be observed up to 5 dpf
(Supplementary Fig. 7). As the heartstring phenotype is an
extreme manifestation of a stretched heart and extensive edema,
the loss of the BA in FGF signaling-perturbed embryos is not
likely to occur due to apoptosis caused by the observed edema.
FGF8 depletion in mouse results in aberrant OFT development,
including severe aortic arch defects, a structure probably most
comparable to the teleost BA57,58. We only observed complete
failure of BA formation when all FGF signaling was blocked
before cardiac cone stages, but not when perturbed later during
heart tube stages or by sub-penetrant doses of SU5402 (Fig. 7r–l).
Our data are consistent with two effects of FGF signaling on
zebrafish heart development after initial cardiac specification:
first, FGF signaling regulates ventricular myocardium formation
during medial migration of ventricular progenitors and cardiac
cone formation; second, FGF signaling controls smooth-muscle
precursors residing in the pharyngeal ALPM prior to their OFT
addition. Work on chick SHF explants has established that loss of
FGF signaling blocks proliferation and causes myocardial differ-
entiation, while elevating FGF signaling drives SHF cells into
smooth-muscle fates59. In Ciona, an FGF-driven regulatory cir-
cuit controls key cardiopharyngeal transcription factors including
Tbx1/10 and regulates cell-cycle dynamics to permit differentia-
tion of individual cardiac lineages10,60,61. These results are in line
with our temporal and dose requirement for FGF during zebra-
fish ventricle and OFT formation (Fig. 7), suggesting that BA
progenitors already have an assigned fate during heart cone for-
mation. Regulation of OFT progenitors while they reside in the
pharyngeal LPM points toward an FGF activity gradient mediated
by adjacent structures.
Of note, we also detected a late-differentiating cardiomyocyte
population at the venous pole, the IFT, of the heart (Fig. 4a–c), in
accordance with previous findings of late IFT myocardial differ-
entiation27. tbx1 reporter-expressing cells at the IFT con-
comitantly expressed Isl1, confirming their SHF signature
(Fig. 2i–p). We did not detect any Isl1 expression at the OFT, in
accordance with other studies in zebrafish implicating Isl1 in IFT
development25,27,46. We detected Isl1+ IFT cells that seemingly
did not express the tbx1 reporter at the time point of analysis
(~22.7% of all Isl1-expressing IFT cells; Fig. 2q, Supplementary
Movie 2). Whether this result is a consequence of dynamic tbx1:
EGFP reporter expression or is indicative of late-differentiating
IFT subpopulations with distinctive gene-expression signatures
deserves a more detailed analysis. While we here focused on the
development of the arterial pole, these observations warrant
application of our tbx1 reporter transgenics for the elucidation of
zebrafish IFT formation.
Altogether, our data provide new insights into the dynamics of
ventricle and OFT formation and integrate their mechanistic
separation as distinct phases of a continuous developmental
process in zebrafish.
Methods
Animal husbandry. Zebrafish (Danio rerio) were maintained, collected, and staged
principally as described62 and in agreement with procedures mandated by the
veterinary office of UZH and the Canton of Zürich, or in accordance with the
guidelines of the Max Delbrück Center for Molecular Medicine and the local
authority for animal protection (Landesamt für Gesundheit und Soziales, Berlin,
Germany) for the use of laboratory animals, and following the “Principles of
Laboratory Animal Care” (NIH publication no. 86–23, revised 1985) as well as the
current version of German Law on the Protection of Animals. Embryos were raised
in temperature-controlled incubators without light cycle at 28 °C unless specified
differently in the text.
Vectors and transgenic lines. All transgenic lines newly generated in this work
have been assigned unique ZFIN designations. The upstream cis-regulatory region
of the zebrafish tbx1 gene (ZDB-GENE-030805-5) was amplified from zebrafish
wild-type genomic DNA with primers 5′-GCTTATACGCACGACTGC-3′ (forward)
and 5′-TGTGTCGATCGCGTATCGC-3′ (reverse) with the Expand Hi-Fidelity PCR
kit (Roche). The 3242-bp upstream region of tbx1 was TOPO-cloned into the
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04402-6 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:2001 | DOI: 10.1038/s41467-018-04402-6 |www.nature.com/naturecommunications 11
pENTR™ 5′-TOPO® TA Cloning® plasmid (Cat#59120; Invitrogen) according to the
manufacturer’s instructions to obtain pAF006 (pENTR/5′_tbx1).
Subsequent cloning reactions were performed with the Multisite Gateway
system with LR Clonase II Plus (Cat#12538120; Life Technologies) according to the
manufacturer’s instructions.
tbx1:EGFP (pAF008 or pDestTol2pA2_tbx1:EGFP) and tbx1:H2B-Dendra2
(pAF048 or pDestTol2pA2_tbx1:H2B-Dendra2) were assembled from pAF006
together with Tol2kit #383 (pME-EGFP) or pKP003 (pME-H2B-Dendra2, cloned
from p55-H2B-Dendra263), #302 (p3E_SV40polyA), and #394 (pDestTol2A2) as
backbone64. pAF008 was used to generate transgenic strain Tg(–3.2tbx1:EGFP)zh702
based on founder line I and the additional lines for comparison, as depicted in
Supplementary Fig. 1 to ensure faithful transgene expression. pAF048 was used to
generate transgenic strain Tg(–3.2tbx1:H2B-Dendra2)zh704, one of two lines that
showed basically identical expression and optogenetic properties (see also text for
details and Supplementary Fig. 5).
We cloned tbx1:creERT2 (pAF038 or pDestTol2CY_tbx1:creERT2,alpha-
crystallin:Venus) by combining pAF006 with pCM293 (pENTR/D_creERT2)65,
Tol2kit vector #30264, and pCM326 (pDestTol2CY, containing the alpha-crystallin:
Venus cassette as transgenesis marker) as backbone21. This vector was used to
generate transgenic strain Tg(–3.2tbx1:creERT2,cryaa:Venus)zh703, which we
selected as the best line after screening several transmitting founders (see also text
for details).
The transgene hsp70l:Switch (pAF040 or pDestTol2CY_hsp70l:loxP-STOP-loxP-
EGFP,alpha-crystallin:Venus) was assembled from pDH08366 by transfer of the
loxP cassette into pENTR5’ (generating pENTR/5′_hsp70l:loxP-STOP-loxP), Tol2kit
#383 and #30264, and pCM326 as backbone. This vector was used to generate the
transgenic strain with ZFIN designation Tg(–1.5hsp70l:loxP-STOP-loxP-EGFP,
cryaa:Venus)zh701.
For Tol2-mediated zebrafish transgenesis, 25 ng/µL Tol2 mRNA were injected
with 25 ng/µL plasmid DNA64,67. F0 founders were screened for specific EGFP or
alpha-crystallin:YFP expression, raised to adulthood, and screened for germline
transmission. Single-insertion transgenic strains were established and verified
through screening for a 50% germline transmission rate in outcrosses in the
subsequent generations as per our previously outlined procedures67.
For tbx1:EGFP, lines with more than one insertion were not followed up (lines
III and VI, see Supplementary Table 1) and of the remaining four lines, three were
retained: lines I (Tg(–3.2tbx1:EGFP_I)zh702), IV, and V. Due to its clean expression
pattern without unspecific signals, experiments were performed in line I in
generation F2 or beyond (Supplementary Table 1, Supplementary Fig. 1), and some
experimental outcomes confirmed in the other retained lines. For tbx1:creERT, two
lines were isolated and retained. The main experiments were performed in line II
(Fig. 2s–u, Supplementary Fig. 2) due to higher and more stable switching
mosaicism observed in the heart compared to line I (Supplementary Fig. 3). For
tbx1:Dendra2, two lines were isolated and retained, line I and line II; all
experiments were performed in line II due to the unclean insertion pattern
observed in line I (Supplementary Fig. 5).
Additional already-established transgenic lines used in this study included drl:
mCherry (Tg(–6.3drl:mCherry)zh705)68, myl7:DsRed269, ubi:Switch65, and drl:
creERT221.
Morpholino injections. The previously characterized and validated55,56 fgf8aATG
and tbx5aATG morpholinos (MO3-fgf8aATG: 5′-GAGTCTCATGTTTA-
TAGCCTCAGTA-3′; ZFIN ID: ZDB-MRPHLNO-050714-1, MO2-tbx5aATG: 5′-
CCTGTACGATGTCTACCGTGAGGC-3′; ZFIN ID: ZDB-MRPHLNO-060328-3),
as well as the standard control morpholino (5′-CCTCTTACCTCAGTTA-
CAATTTATA-3′) were obtained by Gene Tools, LLC and injected in the yolk of
one- to four cell-stage embryos.
Agarose sections. Transverse sections of agarose-embedded embryos at 3 dpf
were performed essentially as previously described47: embryos were fixed in 4%
paraformaldehyde (PFA), embedded in 6% low-melting-point agarose (Sigma), cut
into 130-mm vibratome sections (VT1000S, Leica), and mounted with DAPI-
containing Vectashield (Cat#H-1200; Vector Laboratories).
Whole-mount in situ hybridization. First-strand complementary DNA (cDNA)
was generated from wild-type zebrafish RNA isolated with Superscript III First-
Strand Synthesis kit (Cat#18080051; Invitrogen). DNA templates were generated
using first-strand cDNA as PCR template and the following primers: EGFP with 5′-
ATGGTGAGCAAGGGCGAGGAGC-3′ (forward) and 5′-TAATACGACTCACTA-
TAGGG-3′(reverse); tbx1 with 5′-TATTCCGGATCCAACTCAGC-3′ (forward) and
5′-TTATCTGGGTCCGTAGTC-3′ (reverse). For in vitro transcription, the T7 RNA
polymerase promoter 5′-TAATACGACTCACTATAGGG-3′ was added to the 5′-
end of reverse primers. In situ hybridization probes were made by in vitro tran-
scription using T7 RNA polymerase and DIG-labeled NTPs (Cat#11277073910;
Roche). RNA was precipitated with lithium chloride in ethanol and dissolved in
DEPC water. Embryos were fixed in 4% PFA overnight at 4 °C, transferred into
100% methanol, and stored at −20 °C until in situ hybridization. In situ hybridi-
zation of whole-mount zebrafish embryos was performed according to published
protocols70.
Antibody staining. Embryos were fixed in 4% formaldehyde, 0.1% TritonX in
PEM (0.1 M PIPES, 2 mM MgSO4, and 1 mM EDTA) for 2–4 h at room tem-
perature, washed in 0.1% PBS TritonX (PBSTx), and permeabilized in 0.5% PBSTx.
Hearts from 26-, 54-, and 72-hpf zebrafish embryos were dissected in Tyrode’s
solution (136 mM NaCl, 5.4 mM KCl, 1 mM MgCl2 × 6H2O, 5 mM D (+)glucose,
10 mM HEPES, 0.3 mM Na2HPO4 × 2H2O, and 1.8 mM CaCl2 × 2H2O; pH 7.4)
with 20 mg/mL BSA and fixed with Shandon™ Glyo-Fixx™ (Cat#9990920; Thermo
Fisher Scientific™) for 20 min at room temperature. Blocking was done in blocking
buffer containing 5% goat serum, 5% BSA, 20 mM MgCl2 in PBS, and embryos/
hearts incubated with primary antibodies diluted in blocking buffer at 4 °C over-
night. Primary antibodies used were anti-MHC (MF20 supernatant, DSHB, 1:50),
anti-GFP (Abcam, ab13970, 1:500 or Sigma, G1544, 1:100), and anti-Isl1 (GeneTex,
GTX128201, 1:50). Alexa-conjugated secondary antibodies (A11039, A11004,
A11008, and A11012 ThermoFisher Scientific) were added at 1:500 in 0.1% PBSTx
at 4 °C overnight. Embryos were washed several times in 0.1% PBSTx. DAPI-
containing Vectashield was added and embryos were kept in the mounting med-
ium until imaging. Before imaging, embryos were mounted in 1% low-melting-
point agarose. Dissected hearts were washed overnight in blocking buffer and
mounted in the ProLong Gold antifade reagent with DAPI (Cat#P36935; Ther-
moFisher Scientific™).
CreERT2-based lineage tracing. Lineage-tracing experiments were performed by
crossing female hsp70l:Switch or ubi:Switch reporter carriers with male creERT2
driver transgenics67. Embryos were induced using 4-OHT (Cat#H7904: Sigma)
from fresh and/or preheated (65 °C for 10 min) stock solutions in DMSO with a
final concentration of 10 μM in E3 embryo medium as per our established pro-
tocols47. Heat-shocks were performed for 60 min at 37 °C in glass tubes in a water
bath.
Microscopy and image analysis. Stereomicroscopy images were obtained on a
Leica M205FA equipped with a Leica DFC450C digital camera. Confocal images of
transverse sections were obtained on an inverted Zeiss LSM710 confocal micro-
scope with a Plan-Apochromat ×40/1.3 Oil DIC M27 objective. Confocal imaging
of whole-mounts and dissected hearts was done with a Leica SP8 upright confocal
microscope using a HC PL APO ×20/0.5 water objective and Leica SP8 inverted
confocal microscope using a HC PL APO CS2 ×63 glycerol/NA 1.3 objective,
respectively.
SPIM/lightsheet microscopy was performed on a Zeiss Z.1. Embryos were
embedded in 1% low-melting-point agarose and 0.016% ethyl 3-aminobenzoate
methanesulfonate salt (Tricaine, Cat#A5040; Sigma) in E3 embryo medium in a 50-
µL glass capillary. Heartbeat was stopped with 30 mM 2,3-butanedione monoxime
(BDM, Cat#B0753; Sigma) as indicated in individual experiments.
Dendra2 photoconversion experiments were performed on an inverted Zeiss
LSM710 confocal microscope with the Plan-Apochromat ×20/0.8 M27 or LD LCI
Plan-Apochromat ×25/0.8 Imm Korr DIC M27 objectives. Embryos were
embedded in 1% low-melting-point agarose and 0.016% tricaine in E3 embryo
medium in glass-bottom plates orienting the anterior dorsal side of the embryo
toward the bottom of the plate.
Panoramic SPIM and high-resolution SPIM of the beating zebrafish heart, as
well as image processing (Mercator projections and reconstruction of the beating
heart) were performed essentially as described44,48.
Images were processed using Leica LAS, ImageJ/Fiji, Imaris, and Photoshop
CS6. The area of the BA, ventricle, and regions positive for drl:EGFP was measured
from confocal image Z-projections of dissected hearts using ImageJ/Fiji.
Chemical treatments. SU5402 (Sigma) was administered to embryos at con-
centrations ranging from 2 to 5 µM in E3 at desired stages and for specific periods
of time as indicated in the text. The drug was washed out through several washing
steps with E3. Diaminorhodamine-4M AM solution (DAR-4M, Cat#D9194; Sigma)
was diluted 1:1000 in E3 containing 0.003% 1-phenyl-2-thiourea (PTU, Cat#P7629;
Sigma) and live embryos were incubated in the staining solution for at least 48 h at
28 °C. DAR-4M was washed out through several washing steps before imaging.
Controls were treated with equivalent amounts of DMSO.
Statistical analysis. Statistical tests were performed with GraphPad Prism 7.04.
All tests were performed as two-tailed, unpaired t-tests with Welch correction.
Statistical significance was determined by a P-value ≤ 0.05 (ns P > 0.05, *P ≤ 0.05,
**P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001).
Data availability. The authors declare that all data supporting the findings of this
study are available within the article and its Supplementary Information files or
from the corresponding author upon reasonable request.
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